Health and Healthcare
1486 Articles
Pfizer Inc. (NYSE: PFE) has a big day ahead of it. While it has been known for years, it is…
It now costs about $1 billion to get a new drug to market, or, if a company is unlucky, $1…
The supercommittee appears unlikely to settle on a deficit agreement. (Reuters) A senior Chinese official says he expects the global…
Some companies just want to keep bringing on new share buybacks whether they work or not. Some are to stop…
The economic choppiness is coming to a head with the age of dividend hikes. The pressure is going to remain…
George Papandreou convinces the Greek cabinet of the virtues of a national referendum on budget cuts, but he now faces…
The markets are beyond jittery. From a massively overbought market discounting a recession entirely back to a market dominated by the…
Earnings season is still running strong and the economic readings keep coming out as well. As we come to the…
Short sellers moved out of stocks that have fallen recently. Perhaps they believe there will be a large rally in…
Novartis (NYSE: NVS) said it would cut 2,000 workers and outsource some functions to companies that will do the work…
A company can spend billions of dollars on R&D and get little respect as an innovator. Even though that is…
Drug maker Eli Lilly & Co. (NYSE: LLY) reported third-quarter earnings this morning, and the company did a little better…
Sales for the big pharmaceutical companies are expected to be hit by pricing pressure in Europe, a lack of urgent…
The 30-Year Treasury auction, the so-called Long Bond, had a strong participation for what is technically a 29-year and 11-month…
Jon OggThese are some of this Wednesday’s top analyst upgrades, downgrades, and initiations seen having an impact from Wall Street…
Our top personal finance-related articles today. Your wallet will thank you later.